ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999